Trials / Completed
CompletedNCT01619436
The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass
The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Federal University of Juiz de Fora · Academic / Other
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clonidine | bolus, clonidine 2 mg/kg IV |
| DRUG | Ringer lactato | 1 ML ringer lactato IV, as placebo |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-05-01
- First posted
- 2012-06-14
- Last updated
- 2012-06-14
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01619436. Inclusion in this directory is not an endorsement.